Library
Registered on ClinicalTrials
Results of a Randomized, Double-Blind, Multicenter, Placebo-Controlled, Parallel-Group Study of the Effi Cace and Safety of Mexidol in Prolonged Sequential Therapy of Patient S in the Acute and Early Recovery Stages of Hemisphereic Stroke (The Epica Study)
Authors:
LV Stakhovskaya 1 , Na Shamalov 1 , DR Khasanova 2 , Ev Mel'nikova 3 , AS AGAF'INA 4 , KV Golikov 5 , AA Yakupova 6 , LV Roshkovskaya 7 , LV LUKINYKH 8 , T. M Lokshtanova 9 , Ie Poverennova 10 , La SHEPANKEVICH 11
1 Research Institute of Cerebrovascular Pathology and Stroke, Pirogov Russian National Research Medical University, Russian Ministry of Health, Moscow, Russia.
2 Interregional Clinical Diagnostic Center, Kazan, Russia.
3 St. Petersburg City Clinical Hospital No. 26, St. Petersburg, Russia.
4 St. Petersburg City Clinical Hospital No. 40 of the Resort Administrate District, St. Petersburg, Russia.
5 St. Petersburg City General Hospital no. 2, St. Petersburg, Russia.
6 Kazan Sate Medical University, Russian Ministry of Health, Kazan, Russia.
7 Nikolaevskaya Hospital, St. Petersburg, Russia.
8 Vsevolzhsk Clinical Internal Hospital, Leningradskaya Oblast, Russia.
9 Pirogov City Clinical Hospital No. 1, Samara, Russia.
10 SEREDAVIN SAMARA Regional Clinical Hospital, Samara, Russia.
11 Research Institute of Experimental and Clinical Medicine, Novosibirsk, Russia.
Place of publication:
Neuroscience and Behavioral Physiology, Vol. 48, no. 8, October, 2018
Vegetative dysfunction in patients with cerebrovascular diseases and metabolic syndrome
Author:
V.N. Shishkova
FGBU NMIC TPM Ministry of Health of Russia, Moscow, Russia
The results of a cohort -center randomized study of the modulating effect of Mexidol® in the rehabilitation of patients who have undergone acute cerebral failure
Registered on ClinicalTrials
A.A. BELKIN, V.A. BELKIN, I.E. VASILCENKO, E.A. PINCHUK
ANO "Clinical Institute of the Brain", Sverdlovsk region, Berezovsky, Russia
Link to the study here
Place of publication:
a journal of neurology and psychiatry named after S.S. Korsakova, 2024, T. 124, No. 4
The effectiveness of the use of Mexidol in combination with revascularization of the brain in the treatment of ischemic stroke
Authors:
A.M. Alaseev 1 , E.V. LANTSOVA 2
1 GAUZ SS "Sverdlovsk Regional Clinical Hospital No. 1", Yekaterinburg, Russia;
2 LLC "Sinsfiles", Yekaterinburg, Russia
Pharmacological correction of the cognitive status of patients with post -shoe syndrome
Author:
L.V. Chichanovskaya, T.A. Slyusar, Yu.V. Abramenko, T.M. Nekrasova, I.N. Slyusar
FSBEI in the Tver State Medical University of the Ministry of Health of Russia, Tver
The effectiveness of Mexidol Correction in the correction of the post -shoe syndrome in patients with chronic cerebrovascular diseases
Authors:
E.B. Kuznetsova, E.A. Salina, N.S. Kuznetsov
FSBEI in "Saratov State Medical University named after V.I. Razumovsky "Ministry of Health of Russia, Saratov, Russia
Clinical and psychological profile and quality of life of patients with post-shoe syndrome
Authors:
L.V. Chichanovskaya, T.A. Slyusar, Yu.V. Abramenko, T.M. Nekrasova, I.N. Slyusar
FSBEI in the Tver State Medical University of the Ministry of Health of Russia, Tver, Russia
Features of the treatment and rehabilitation of patients who suffered Covid-19 with ischemic stroke
Authors:
G.S. Rakhimbayeva, Sh.R. Gazieva, M.K. Atyaniyazov, F.Kh. Muratov, D.S. Tolipov, U.D. Shodiev
Tashkent Medical Academy, Tashkent, Republic of Uzbekistan
Neurological manifestations of post -shoe syndrome
Authors:
P.R. Kamchatnov 1 , R.A. Cheremin 2 , L.A. Scepterova 2 , A.V. Chugunov 1
1 FBGOU in Russian National Research Medical University named after N.I. Pirogov »Ministry of Health of Russia, Moscow, Russia;
2 GBUZ "Center for Pathology of Speech and Neurorebition of the Moscow Department of Health", Moscow, Russia.
Frequent neurological symptoms of Long-Covid and their correction paths
Author
Ostroumova T.M. - Ph.D., assistant department of the department of nervous diseases and neurosurgery of the Institute of Clinical Medicine named after N.V. Sklifosovsky FGAOU in the First MGMU named after THEM. Sechenova of the Ministry of Health of Russia (Sechenov University)
Place of publication:
03.2022
The use of Mexidol in patients with chemical and covid-19
Author:
A.I. Fedin
FGAOU in Russian National Research Medical University named after N.I. Pirogov »Ministry of Health of Russia, Moscow, Russia
Asthenia and cognitive disorders against the background of the transformed infections of the Covid-19: possible correction routes
Author:
Ostroumova T.M.
FGAOU in "First Moscow State Medical University named after THEM. Sechenov "Ministry of Health of Russia (Sechenov University), Moscow, Russia
The possibilities of increasing the effectiveness of patients with chronic brain ischemia against the background of Covid-19
Authors:
V.V. Kovalchuk, I.I. Ershova, N.V. Molodovskaya
St. Petersburg GBUZ "City Hospital No. 38 named after N.A. Semashko ", St. Petersburg, Russia
The role of antioxidant therapy in patients with the new coronavirus infection of the Covid-19 of the Motenza and Severe
Authors:
E.K. Shavarova 1.2 , E.R. Kazamedov 1 , M.V. Alekseeva 1 , L.G. Yezhova 2 , railway Cobalava 1
1 Russian University of Friendship of Peoples (RUDN), Moscow, Russian Federation;
2 City Clinical Hospital named after V.V. Vinogradov Department of Health of the city of Moscow, Moscow, Russian Federation
The role of free-radical oxidation, hypoxia and their correction in the pathogenesis of Covid-19
Author:
A.V. Schulkin, A.A. Filimonova
FGBOU in the Ryazan State Medical University named after Acad. I.P. Pavlova "of the Ministry of Health of Russia
Antioxidants/Antihyxants-the missing puzzle of effective pathogenetic therapy of patients with Covid-19
Author:
T.A. Voronin
Research Institute of Pharmacology. V.V. Zakusova, Moscow, Russian Federation
THE INFORMATION IS INTENDED FOR HEALTHCARE AND PHARMACEUTICAL PROFESSIONALS. THIS INFORMATION IS NOT INTENDED AS A SUBSTITUTE FOR MEDICAL ADVICE.
Source of photos and images Shutterstock.com